Continued low-dose glucocorticoid maintenance therapy in ANCA-associated vasculitis does not reduce major relapse risk but can increase damage accrual.

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

Researchers evaluated the efficacy of secukinumab plus a glucocorticoid taper for achieving sustained remission in polymyalgia rheumatica.

Higher body mass index is linked to reduced odds of achieving minimal disease activity in psoriatic arthritis.

Erica Schwartz, MD, MPH, JD, becomes the new CDC director as the nation faces surging measles cases and parasitic outbreaks.

In adults with type 2 diabetes, use of GLP-1 receptor agonists is associated with an increased risk for incident nonscarring alopecia.

Ultra-high frequency ultrasound of the labial salivary glands may accurately classify Sjögren disease and reduce the need for biopsy.

Healthy plant-based diets are associated with lower CVD, T2D, and mortality risks regardless of food processing levels.

Patients with systemic lupus erythematosus have an increased risk of developing bronchiectasis, which is linked to higher mortality rates.

An overview of 5 FDA Priority Review PDUFA decision dates in September 2026, covering novel treatments in rare neurological disorders, oncology, and adolescent cardiology.

A combination of leflunomide and hydroxychloroquine may reduce systemic disease activity in active Sjögren disease.

Significant disproportionality signals have been identified for adverse drug events (ADEs) linked to apremilast, according to study results published in Experimental Dermatology.